NO20050141D0 - Prodrugs av imidazolderivater for anvendelse som protonpumpeinhibitorer ved behandlingen av f.eks. peptisk ulcus - Google Patents

Prodrugs av imidazolderivater for anvendelse som protonpumpeinhibitorer ved behandlingen av f.eks. peptisk ulcus

Info

Publication number
NO20050141D0
NO20050141D0 NO20050141A NO20050141A NO20050141D0 NO 20050141 D0 NO20050141 D0 NO 20050141D0 NO 20050141 A NO20050141 A NO 20050141A NO 20050141 A NO20050141 A NO 20050141A NO 20050141 D0 NO20050141 D0 NO 20050141D0
Authority
NO
Norway
Prior art keywords
prodrugs
treatment
proton pump
imidazole derivatives
peptic ulcer
Prior art date
Application number
NO20050141A
Other languages
English (en)
Other versions
NO20050141L (no
Inventor
Keiji Kamiyama
Hiroshi Banno
Fumihiko Sato
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20050141D0 publication Critical patent/NO20050141D0/no
Publication of NO20050141L publication Critical patent/NO20050141L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20050141A 2002-06-14 2005-01-11 Prodrugs av imidazolderivater for anvendelse som protonpumpeinhibitorer ved behandlingen av f.eks. peptisk ulcus NO20050141L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002175086 2002-06-14
JP2003041085 2003-02-19
PCT/JP2003/007546 WO2003105845A1 (en) 2002-06-14 2003-06-13 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

Publications (2)

Publication Number Publication Date
NO20050141D0 true NO20050141D0 (no) 2005-01-11
NO20050141L NO20050141L (no) 2005-01-27

Family

ID=29738411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050141A NO20050141L (no) 2002-06-14 2005-01-11 Prodrugs av imidazolderivater for anvendelse som protonpumpeinhibitorer ved behandlingen av f.eks. peptisk ulcus

Country Status (19)

Country Link
US (2) US7410981B2 (no)
EP (2) EP1514870A4 (no)
JP (1) JPWO2003106429A1 (no)
KR (1) KR20050009751A (no)
CN (1) CN1678315A (no)
AR (1) AR040221A1 (no)
AT (1) ATE437642T1 (no)
AU (2) AU2003242390A1 (no)
BR (1) BR0311801A (no)
CA (2) CA2489470A1 (no)
DE (1) DE60328603D1 (no)
IL (1) IL165562A0 (no)
MX (1) MXPA04012396A (no)
NO (1) NO20050141L (no)
OA (1) OA12867A (no)
PE (1) PE20040563A1 (no)
PL (1) PL373085A1 (no)
TW (1) TW200307544A (no)
WO (2) WO2003106429A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1740571E (pt) 2004-04-28 2009-09-02 Hetero Drugs Ltd Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
EP2275088B2 (en) 2005-02-25 2018-09-26 Takeda Pharmaceutical Company Limited Method for producing granules
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
AU2009215514B9 (en) 2008-02-20 2014-01-30 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
ES2601226T3 (es) 2009-10-28 2017-02-14 Newlink Genetics Corporation Derivados de imidazol como inhibidores de IDO
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
WO2016172436A1 (en) * 2015-04-23 2016-10-27 Temple University-Of The Commonwealth System Of Higher Education Polycationic amphiphiles and polymers thereof as antimicrobial agents and methods using same
DK3757107T3 (da) * 2016-06-21 2023-11-27 Univ Columbia 4-oxo-3,4-dihydrothieno[3,4-d]pyridazinforbindelser som aldosereduktasehæmmere og metoder til anvendelse deraf
WO2018081347A1 (en) 2016-10-26 2018-05-03 Temple University-Of The Commonwealth System Of Higher Education Polycationic amphiphiles as antimicrobial agents and methods using same
CA3071114A1 (en) 2017-07-28 2019-01-31 Applied Therapeutics Inc. Compositions and methods for treating galactosemia
AU2021293694B2 (en) * 2020-06-17 2023-12-21 Ildong Pharmaceutical Co., Ltd. Novel Acid Secretion Inhibitor and use thereof
IT202200001022A1 (it) * 2022-01-21 2023-07-21 Exo Lab Italia Composti farmaceutici ibridi ottenuti mediante coniugazione di un inibitore delle pompe protoniche e un inibitore delle anidrasi carboniche

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
KR890000387B1 (ko) * 1984-09-24 1989-03-16 디 엎존 캄파니 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
DE19832060C2 (de) * 1998-07-16 2000-07-06 Siemens Ag Doppelbare Prozessoreinrichtung
US6542966B1 (en) * 1998-07-16 2003-04-01 Intel Corporation Method and apparatus for managing temporal and non-temporal data in a single cache structure
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
PL352834A1 (en) * 1999-04-09 2003-09-08 Abbott Gmbh & Co.Kg Prodrugs of thrombin inhibitors
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
ATE499103T1 (de) * 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
AU2001294228A1 (en) 2000-10-12 2002-04-22 Takeda Chemical Industries Ltd. Benzimidazole compounds, process for producing the same and use thereof
MXPA03011094A (es) * 2001-05-31 2004-12-06 Medarex Inc Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello.
US20040248941A1 (en) 2001-09-25 2004-12-09 Keiji Kamiyama Benzimidazone compound, process for producing the same, and use thereof

Also Published As

Publication number Publication date
PL373085A1 (en) 2005-08-08
JPWO2003106429A1 (ja) 2005-10-13
MXPA04012396A (es) 2005-06-17
KR20050009751A (ko) 2005-01-25
CA2489361A1 (en) 2003-12-24
ATE437642T1 (de) 2009-08-15
IL165562A0 (en) 2006-01-15
US7410981B2 (en) 2008-08-12
DE60328603D1 (de) 2009-09-10
CN1678315A (zh) 2005-10-05
OA12867A (en) 2006-09-15
NO20050141L (no) 2005-01-27
CA2489470A1 (en) 2003-12-24
US20050222210A1 (en) 2005-10-06
TW200307544A (en) 2003-12-16
PE20040563A1 (es) 2004-10-21
WO2003106429A1 (ja) 2003-12-24
EP1514870A1 (en) 2005-03-16
AU2003242390A1 (en) 2003-12-31
AR040221A1 (es) 2005-03-16
WO2003105845A1 (en) 2003-12-24
US20060293371A1 (en) 2006-12-28
EP1513527A1 (en) 2005-03-16
AU2003242388A1 (en) 2003-12-31
BR0311801A (pt) 2005-04-12
EP1514870A4 (en) 2006-08-23
EP1513527B1 (en) 2009-07-29

Similar Documents

Publication Publication Date Title
NO20050141D0 (no) Prodrugs av imidazolderivater for anvendelse som protonpumpeinhibitorer ved behandlingen av f.eks. peptisk ulcus
NO20081636L (no) FAP - inhibitorer
NO20055680D0 (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
WO2005030751A3 (en) Dipeptidyl peptidase inhibitors
NO20053215D0 (no) Pyrazolderivater med anvendelse som COX-1-inhibitorer.
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
DK1586319T3 (da) Thiadiazolidinoner som GSK-3-inhibitorer
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
NO20075099L (no) Alkynyl-pyrrolopyrmidiner og relaterte analoger som HSP90-inhibitorer
EA200801413A1 (ru) Гетероциклические сетр ингибиторы
ATE406156T1 (de) Ajulemische säure zur krebsbehandlung
DK1353904T3 (da) 1-Aryl- eller 1-alkylsulfonylbenzazolderivater som 5-hydroxytryptamin-6-ligander
DK1801108T3 (da) Morpholinforbindelser til behandling af inflammationer.
NO20030706D0 (no) Substituerte imidazoler som TAFIA inhibitorer
DK1828166T3 (da) Hydantoinderivater, der kan anvendes som metalloproteinase-inhibitorer
ATE439359T1 (de) Inhibitoren der cdc25 phosphatase
DK1228073T3 (da) Imidazolforbindelser som phosphodiesterase VII-inhibitorer
NO20054053D0 (no) Triazolforbindelser anvendbare i terapi.
HK1072379A1 (en) Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
BR0307595A (pt) Uso de inibidores de pde5 tal como sildenafil no tratamento de sìndrome de ovário policìstico
NO20045025L (no) Nye forbindelser
IS7970A (is) PDE4-hemlar til að meðhöndla eitlafrumuæxli
EA200801296A1 (ru) Способ лечения метаболического синдрома

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application